Lvw Advisors, LLC Charles River Laboratories International, Inc. Transaction History

Lvw Advisors, LLC

$804 Million
Q4 2024

A detailed history of Lvw Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Lvw Advisors, LLC holds 3,058 shares of CRL stock, worth $511,542. This represents 0.07% of its overall portfolio holdings.

Number of Shares

3,058

Previous 3,468 11.82%

Holding current value

$511,542

Previous $683,000 17.42%

% of portfolio

0.07%

Previous 0.09%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	SELL	$178.58 - $220.69 $73,217 - $90,482	-410 Reduced 11.82%	3,058 $564,000
Q3 2024 Oct 09, 2024	BUY	$187.96 - $245.29 $68,229 - $89,040	363 Added 11.69%	3,468 $683,000
Q2 2024 Jul 15, 2024	BUY	$206.39 - $268.73 $55,518 - $72,288	269 Added 9.49%	3,105 $641,000
Q1 2024 Apr 17, 2024	SELL	$203.52 - $273.43 $12,414 - $16,679	-61 Reduced 2.11%	2,836 $768,000
Q4 2023 Jan 12, 2024	SELL	$164.52 - $238.84 $7,896 - $11,464	-48 Reduced 1.63%	2,897 $684,000
Q3 2023 Oct 10, 2023	SELL	$194.44 - $217.61 $51,332 - $57,449	-264 Reduced 8.23%	2,945 $577,000
Q2 2023 Jul 14, 2023	SELL	$183.71 - $210.25 $6,062 - $6,938	-33 Reduced 1.02%	3,209 $674,000
Q1 2023 May 02, 2023	SELL	$191.89 - $259.92 $18,229 - $24,692	-95 Reduced 2.85%	3,242 $654,000
Q4 2022 Jan 18, 2023	SELL	$197.11 - $250.07 $49,671 - $63,017	-252 Reduced 7.02%	3,337 $0
Q3 2022 Oct 13, 2022	BUY	$182.44 - $250.54 $16,602 - $22,799	91 Added 2.6%	3,589 $706,000
Q2 2022 Jul 22, 2022	BUY	$204.13 - $302.4 $37,151 - $55,036	182 Added 5.49%	3,498 $748,000
Q1 2022 May 02, 2022	SELL	$255.51 - $362.11 $45,736 - $64,817	-179 Reduced 5.12%	3,316 $942,000
Q4 2021 Jan 26, 2022	SELL	$351.38 - $448.68 $20,731 - $26,472	-59 Reduced 1.66%	3,495 $1.32 Million
Q3 2021 Nov 02, 2021	BUY	$372.64 - $458.3 $15,650 - $19,248	42 Added 1.2%	3,554 $1.47 Million
Q2 2021 Jul 15, 2021	SELL	$294.17 - $371.65 $109,431 - $138,253	-372 Reduced 9.58%	3,512 $1.3 Million
Q1 2021 Apr 19, 2021	BUY	$249.67 - $299.48 $274,886 - $329,727	1,101 Added 39.56%	3,884 $1.13 Million
Q4 2020 Feb 04, 2021	BUY	$222.0 - $252.62 $23,310 - $26,525	105 Added 3.92%	2,783 $695,000
Q3 2020 Oct 29, 2020	BUY	$175.56 - $226.45 $149,226 - $192,482	850 Added 46.5%	2,678 $606,000
Q2 2020 Aug 11, 2020	BUY	$118.84 - $189.72 $217,239 - $346,808	1,828 New	1,828 $319,000

Others Institutions Holding CRL

# of Institutions

710

Shares Held

53.9M

Call Options Held

122K

Put Options Held

239K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.51B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lvw Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lvw Advisors, LLC with notifications on news.

Account